Tissue infiltration of IgG4+ plasma cells in symptomatic patients with ileal pouch-anal anastomosis

Journal of Crohn's and Colitis

Volumn 5, Issue 6, 2011, Pages 570-576

  Navaneethan, Udayakumar ^a   Bennett, Ana E ^a   Venkatesh, Preethi G K ^a   Lian, Lei ^b   Hammel, Jeffrey ^a   Patel, Viral ^a   Kiran, Ravi P ^a   Remzi, Feza H ^a   Shen, Bo ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b THE SIXTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Autoimmune; IgG4; Pouchitis; Primary sclerosing cholangitis

Indexed keywords

IMMUNOGLOBULIN G4;

ADULT; ANASTOMOSIS; ARTICLE; AUTOIMMUNE DISEASE; CELL INFILTRATION; CLINICAL ASSESSMENT TOOL; DEMOGRAPHY; DISEASE ASSOCIATION; ENDOSCOPY SCORE; FEMALE; HUMAN; HUMAN TISSUE; ILEAL POUCH ANAL ANASTOMOSIS; ILEITIS; IMMUNOHISTOCHEMISTRY; INTESTINE BIOPSY; MAJOR CLINICAL STUDY; MALE; PLASMA CELL; POUCHITIS DISEASE ACTIVITY INDEX; PRIORITY JOURNAL; RISK ASSESSMENT; TISSUE INFILTRATION;

ADULT; AUTOIMMUNE DISEASES; BIOPSY; CHOLANGITIS, SCLEROSING; COLITIS, ULCERATIVE; COLONIC POUCHES; ENDOSCOPY, GASTROINTESTINAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLASMA CELLS; POUCHITIS; SEVERITY OF ILLNESS INDEX;

EID: 82255162964     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2011.05.011     Document Type: Article

References (24)

1. Kamisawa T., Okamoto A., Funata N. Clinicopathological features of autoimmune pancreatitis in relation to elevation of serum IgG4. Pancreas 2005, 31:28-31.
2. Hamano H., Kawa S., Horiuchi A., Unno H., Furuya N., Akamatsu T., Fukushima M., Nikaido T., Nakayama K., Usuda N., Kiyosawa K. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001, 344:732-738.
3. Ravi K., Chari S.T., Vege S.S., Sandborn W.J., Smyrk T.C., Loftus E.V. Inflammatory bowel disease in the setting of autoimmune pancreatitis. Inflamm Bowel Dis 2009, 15:1326-1330.
4. Kamisawa T., Funata N., Hayashi Y., Eishi Y., Koike M., Tsuruta K., Okamoto A., Egawa N., Nakajima H. A new clincopathological entity of IgG4-related autoimmune disease. J Gastroenterol 2003, 38:982-984.
5. Kasashima S., Zen Y., Kawashima A., Konishi K., Sasaki H., Endo M., Matsumoto Y., Kawakami K., Kasashima F., Moriya M., Kimura K., Ohtake H., Nakanuma Y. Inflammatory abdominal aortic aneurysm: close relationship to IgG4-related periaortitis. Am J Surg Pathol 2008, 32:197-204.
6. Yamashita K., Haga H., Kobashi Y., Miyagawa-Hayashino A., Yoshizawa A., Manabe T. Lung involvement in IgG4-related lymphoplasmacytic vasculitis and interstitial fibrosis. Am J Surg Pathol 2008, 32:1620-1626.
7. Kamisawa T., Tu Y., Egawa N., Tsuruta K., Okamoto A. A new diagnostic endoscopic tool for autoimmune pancreatitis. Gastrointest Endosc 2008, 68:358-361.
8. Virk R.K., Lauwers G.Y., Deshpande V. The significance of IgG4 in inflammatory bowel disease 2011, United States and Canadian Academy of Pathology, (Abstract).
9. Shen B., Remzi F.H., Nutter B., Bennett A.E., Lashner B.A., Lavery I.C., Brzezinski A., Nutter B., Bambrick M.L., Queener E., Fazio V.W. Association between immune-associated disorders and adverse outcomes of ileal pouch-anal anastomosis. Am J Gastroenterol 2009, 104:655-664.
10. Shen B., Bennett A.E., Navaneethan U. IgG4 associated pouchitis. Inflamm Bowel Dis 2010 Aug 18, [E pub ahead of print].
11. Navaneethan U., Venkatesh P.G., Kapoor S., Kiran R.P., Remzi F.H., Shen B. Elevated serum IgG4 is associated with chronic antibiotic refractory pouchitis - a prospective study. Digestive Disease Week 2011, (Abstract).
12. Shen B., Bennett A.E., Navaneethan U., Lian L., Shao Z., Kiran R.P., Fazio V.W., Remzi F.H. Primary sclerosing cholangitis is associated with endoscopic and histologic inflammation of the distal afferent limb in patients with ileal pouch-anal anastomosis. Inflamm Bowel Dis 2010 Dec 27, [Epub ahead of print].
13. Sandborn W.J., Tremaine W.J., Batts K.P., Pemberton J.H., Phillips S.F. Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clin Proc 1994, 69:409-415.
14. Shen B., Achkar J.P., Connor J.T., Ormsby A.H., Remzi F.H., Bevins C.L., Brzezinski A., Bambrick M.L., Fazio V.W., Lashner B.A. Modified Pouchitis Disease Activity Index: a simplified approach to the diagnosis of pouchitis. Dis Colon Rectum 2003, 46:748-753.
15. Navaneethan U., Shen B. Pros and cons of antibiotic therapy for pouchitis. Expert Rev Gastroenterol Hepatol 2009, 3:547-559.
16. Navaneethan U., Shen B. Diagnosis and management of ileo-anal pouch dysfunction/pouchitis. Curr Gastroenterol Rep 2010, 12:485-494.
17. Chari S.T., Smyrk T.C., Levy M.J., Topazian M.D., Takahashi N., Zhang L., Clain J.E., Pearson R.K., Petersen B.T., Vege S.S., Farnell M.B. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 2006, 4:1010-1016.
18. Morselli-Labate A.M., Pezzilli R. Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: a systematic literature review and meta-analysis. J Gastroenterol Hepatol 2009, 24:15-36.
19. Zen Y., Nakanuma Y. Pathogenesis of IgG4-related disease. Curr Opin Rheumatol 2011, 23:114-118.
20. Mendes F.D., Jorgensen R., Keach J., Katzmann J.A., Smyrk T., Donlinger J., Chari S., Lindor K.D. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol 2006, 101:2070-2075.
21. Zhang L., Lewis J.T., Abraham S.C., Smyrk T.C., Leung S., Chari S.T., Poterucha J.J., Rosen C.B., Lohse C.M., Katzmann J.A., Wu T.T. IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis. Am J Surg Pathol 2010, 34:88-94.
22. Zen Y., Quaglia A., Portmann B. Immunoglobulin G4-positive plasma cell infiltration in explanted livers for primary sclerosing cholangitis. Histopathology 2011, 58:414-422.
23. Navaneethan U., Shen B. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease. Inflamm Bowel Dis 2010, 16:1598-1619.
24. Khosroshahi A., Bloch D.B., Deshpande V., Stone J.H. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum 2010, 62:1755-1762.